Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • De novo genome assembly (Hybrid) - bacterial genome

    Hi,

    I would like to do an de novo genome assembly of a bacterial genome. I already have PacBio data and will now do Illumina sequencing, aditionally. I plan to do HiSeq, as I want to do a SNP analysis too. Which tool can a use to perform a hybrid assembly with PacBio and Illumina HiSeq data? PacBio gives me 5 contigs. Do you think that I can reduce the contigs with my HiSeq data?

    Thank you in advance!!

  • #2
    You probably want to use miSeq in 2x250 for data aquisition.

    A couple of points with respect of experimental design:

    1. Make sure the Illumina libraries are PCR-free prep.
    2. Unless you want to do 96 genomes on one hiseq lane, use MiSeq, since hiseq would give too much data (you would have to subsample), also to ensure that you do 2x250 or 2x300 read length.

    So use Miseq (~10-16 samples per 2x250 or 2x300 run) or Hiseq2500 in 2x250 rapid run mode.

    This would help the downstream analysis (pacbio error correction/assembly) quite a lot. (compared to 2x100 or 2x150 bps read length), especially in the repeat regions.

    Tools:
    Give spades assembler a try...

    Comment


    • #3
      Illumina data are very unlikely stitch your Pacbio contigs together. I would suggest to try different assemblers and parameters on your Pacbio data.

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Understanding Genetic Influence on Infectious Disease
        by seqadmin




        During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

        Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
        09-09-2024, 10:59 AM
      • seqadmin
        Addressing Off-Target Effects in CRISPR Technologies
        by seqadmin






        The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
        08-27-2024, 04:44 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, 09-11-2024, 02:44 PM
      0 responses
      13 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-06-2024, 08:02 AM
      0 responses
      146 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-03-2024, 08:30 AM
      0 responses
      153 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 08-27-2024, 04:40 AM
      0 responses
      163 views
      0 likes
      Last Post seqadmin  
      Working...
      X